Editorial
Published on 14 Dec 2023
Editorial: Implication of oxidative, inflammatory, apoptotic and autophagy pathways in colitis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1326176
- 731 views
Type at least 3 characters
1,606 articles
Articles
Systematic Review
Published on 07 Dec 2023
Efficacy and safety of iguratimod in the treatment of rheumatic and autoimmune diseases: a meta-analysis and systematic review of 84 randomized controlled trials
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1189142
- 2,390 views
- 1 citation
Original Research
Published on 07 Dec 2023
A real-world disproportionality analysis of mepolizumab based on the FDA adverse event reporting system
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1280490
- 1,975 views
Editorial
Published on 06 Dec 2023
Editorial: Lipidomics of oxylipins in biological systems
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1342596
- 1,064 views
Original Research
Published on 29 Nov 2023
ACT001 improved cardiovascular function in septic mice by inhibiting the production of proinflammatory cytokines and the expression of JAK-STAT signaling pathway
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1265177
- 2,101 views
Original Research
Published on 20 Nov 2023
IL-37 counteracts inflammatory injury in the temporomandibular joint via the intracellular pathway
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1250216
- 1,386 views
Review
Published on 16 Nov 2023
Current and promising therapies based on the pathogenesis of Graves’ ophthalmopathy
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1217253
- 2,948 views
- 2 citations
Review
Published on 15 Nov 2023
Immunomodulatory roles of metalloproteinases in rheumatoid arthritis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1285455
- 3,667 views
- 5 citations
Original Research
Published on 10 Nov 2023
Suppression of inflammation-induced lung cancer cells proliferation and metastasis by exiguaflavanone A and exiguaflavanone B from Sophora exigua root extract through NLRP3 inflammasome pathway inhibition
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1243727
- 1,547 views
- 2 citations
Mini Review
Published on 06 Nov 2023
Mechanisms of action of the BCL-2 inhibitor venetoclax in multiple myeloma: a literature review
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1291920
- 3,426 views
- 11 citations
Mini Review
Published on 06 Nov 2023
Role of signaling lymphocytic activation molecule family of receptors in the pathogenesis of rheumatoid arthritis: insights and application
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1306584
- 1,947 views
- 1 citation
Brief Research Report
Published on 01 Nov 2023
Large chemokine binding spectrum of human and mouse atypical chemokine receptor GPR182 (ACKR5)
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1297596
- 1,815 views
- 1 citation
Original Research
Published on 30 Oct 2023
Association of lipid lowering drugs and the risk of systemic lupus erythematosus: a drug target Mendelian randomization
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1258018
- 3,787 views
Original Research
Published on 26 Oct 2023
β-sitosterol alleviates dextran sulfate sodium-induced experimental colitis via inhibition of NLRP3/Caspase-1/GSDMD-mediated pyroptosis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1218477
- 2,521 views
- 3 citations
Correction
Published on 26 Oct 2023
Corrigendum: Naringenin protects against acute pancreatitis-associated intestinal injury by inhibiting NLRP3 inflammasome activation via AhR signaling
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1295494
- 611 views
- 3 citations
Opinion
Published on 23 Oct 2023
Whether MTHFD2 plays a new role: from anticancer targets to anti-inflammatory disease
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1257107
- 1,352 views